The Venture Codex Logo

The Venture Codex

Overview

Specialty pharmaceutical company focused on gastrointestinal diseases.

Founded

1996

Deals ยท 12mo

0

Stage focus

Debt

Geographic focus

United Kingdom

Sector focus

Biotechnology
Health Care
Manufacturing
Pharmaceutical

Investment portfolio

1rounds
NAMEDATESIZE
Acacia Pharma
Oct 2020Led
$29 MDebt
Acacia Pharma
Oct 2020Led
$29 MDebt
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Cosmo Pharmaceuticals: 1 funding rounds are recorded in the selected participation categories.All available history.
Cosmo Pharmaceuticals: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Debt10

Monthly Deal Activity

Cosmo Pharmaceuticals: 1 deals are recorded across 73 months.All available history.
Cosmo Pharmaceuticals: 1 deals are recorded across 73 months. All available history
MonthDeals
Oct '201
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Cosmo Pharmaceuticals: Health & Life Sciences is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Cosmo Pharmaceuticals: Health & Life Sciences is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Health & Life Sciences1

Deal Size Distribution

Cosmo Pharmaceuticals: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Cosmo Pharmaceuticals: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M1
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Cosmo Pharmaceuticals: Europe has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Cosmo Pharmaceuticals: Europe has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
Europe1
Cosmo Pharmaceuticals: No co-investors are recorded in this range.All available history.

Co-Investors

Bubble size = shared deals

No co-investor funds in range

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Cosmo Pharmaceuticals: No co-investors are recorded in this range. All available history
Co-investorShared deals
No data in the selected view.

Investment Strategy

Cosmo Pharmaceuticals: Led accounts for 100% and participating for 0% of round participation.All available history.
Cosmo Pharmaceuticals: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led1100%
Participating00%
Cosmo Pharmaceuticals: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Cosmo Pharmaceuticals: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Alessandro Mazzetti

Chief Medical Officer

Giuseppe Cipriano

Chief Operating Officer

Luigi Moro

Chief Scientific Officer

Marco Lecchi

Head of Internal Audit

Massimo Pedrani

Head of Generics Business Development

Roberto Villa

Chief Manufacturing Officer